A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine
about
Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitorsCXCR4 signaling mediates morphine-induced tactile hyperalgesia.An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injuryPathological and protective roles of glia in chronic painThe "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting gliaProinflammatory cytokines oppose opioid-induced acute and chronic analgesiaEvidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1betaTreatment of Cancer Pain by Targeting CytokinesMetaplasticity and behavior: how training and inflammation affect plastic potential within the spinal cord and recovery after injuryGlial modulators: a novel pharmacological approach to altering the behavioral effects of abused substancesOpioid-induced central immune signaling: implications for opioid analgesiaEvidence that opioids may have toll-like receptor 4 and MD-2 effectsPossible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequencesOpioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesiaPEGylation of interleukin-10 for the mitigation of enhanced pain states.A novel method for modeling facial allodynia associated with migraine in awake and freely moving ratsTargeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain.Biphalin, a Dimeric Enkephalin, Alleviates LPS-Induced Activation in Rat Primary Microglial Cultures in Opioid Receptor-Dependent and Receptor-Independent Manners.The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users.Differentially Severe Cognitive Effects of Compromised Cerebral Blood Flow in Aged Mice: Association with Myelin Degradation and Microglia Activation.Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye diseasePersistent pain facilitates response to morphine reward by downregulation of central amygdala GABAergic function.Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders.Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients.The association between spinal cord trauma-sensitive miRNAs and pain sensitivity, and their regulation by morphine.NADPH-oxidase 2 activation promotes opioid-induced antinociceptive tolerance in mice.Glial TLR4 signaling does not contribute to opioid-induced depression of respiration.Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelaeIbudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes.Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis.Interactions between the immune and nervous systems in pain.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strainsBiphasic effect of curcumin on morphine tolerance: a preliminary evidence from cytokine/chemokine protein array analysis.Involvement of neuronal TGF-β activated kinase 1 in the development of tolerance to morphine-induced antinociception in rat spinal cord.Current gene therapy using viral vectors for chronic painFractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and deathRepeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonistNaloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91phox subunit of NADPH oxidaseRofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain
P2860
Q21203940-04FB1D95-D26E-40E9-BF02-537A1EBC4132Q24624133-47B2FEE5-BE0C-45EB-AC55-994ADCCFEC1EQ24634101-383A2012-02D9-44A5-8047-1C12E4D6D776Q24646738-93412993-0415-49C2-A97E-C2697FACBE43Q24650739-C32296A0-585B-4A4C-9609-5817DCCFBF54Q24650758-96AC64E2-80B8-4208-9924-75350E8EE67CQ24656645-DBD72440-9772-467A-98B6-CBB9C5B8C223Q26779917-7222104F-75DF-4858-963B-9A66FB8536B7Q26828742-1DAC1704-2170-471C-922C-5E1C8A26138EQ27003932-29C8C47F-7241-4C8D-95FB-D7E257BC2DD6Q27021477-8BF0AF5B-5A99-491A-A147-41DAD933C180Q28254885-CD5D28AD-64EF-4A01-A928-8DCA99849D1DQ28274052-801FDF53-5B4D-4DA5-AB94-39F23AC756A0Q28576512-AA98E914-25A4-4385-9373-F2F1CC7E9E75Q33505369-F1B2A2BA-6A0C-4423-8D41-A550D83FD7D4Q33624316-A933032C-1BCF-4CBB-B7BE-EEEFB9FA97F0Q33668659-D68347D7-3585-4CED-BE7F-B41D37AD5D01Q33721292-CFBD2975-2EFE-4D5E-BF4D-2451DFCB9608Q33727021-2450FCEE-A3AF-44C1-8C65-CCF8D7C6347FQ33804516-BFCBF4E8-DB7F-4EEF-BA86-EABE553FABE5Q33869200-9D2EDB45-017D-4394-822C-DE351D215C98Q33923667-B19C56CC-F7AB-46C6-831E-A6A749AB1937Q34054207-07683352-7EB9-460D-AE2E-D8BC5D7103CFQ34119496-D490FB5E-3D3F-48C5-98B8-F8783C7D0E0DQ34254894-635C70D6-13B3-431F-A5EC-508AA6C8B76FQ34285878-339A9173-DB8E-48E5-B9D1-356A01BCEEC9Q34353901-057848F4-B987-4F31-B598-4317F41A915AQ34603199-94D47803-4977-43D7-AF56-B23CCD09AF2FQ34642112-3F94DEFA-CD2B-447F-BF19-70BAD5A8FE02Q34666901-A439AF6F-F4C8-43F6-B490-2485F04C4834Q34799654-A11A515D-ECC4-4B22-8528-F99FCC8D8275Q35122783-FE71919F-B622-4777-A0AA-056068950D67Q35124986-82BD38E9-33F6-4CEA-802A-6DB8374F12BDQ35149088-04F37ACC-D115-43BD-B555-A0712EE5BBBDQ35631488-051BB498-0CD3-41B4-964F-6FCC3D6AE22DQ35658521-87F76FE0-BCEA-4BB0-B9A0-FEDAEE1D4A29Q35779848-033CD974-E6C2-4AFD-8A1D-5E455C5E4234Q35818737-2D98B846-8A1A-42FB-90C3-878713CE0456Q35833987-2F7121C0-A5F5-4E3B-9AAD-4B27888747BEQ35847266-E270BF2C-EF16-4DE9-9D84-2453182C01DD
P2860
A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine
description
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im August 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/08/18)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/08/18)
@nl
наукова стаття, опублікована в серпні 2004
@uk
مقالة علمية (نشرت في 18-8-2004)
@ar
name
A role for proinflammatory cyt ...... y chronic intrathecal morphine
@ast
A role for proinflammatory cyt ...... y chronic intrathecal morphine
@en
A role for proinflammatory cyt ...... y chronic intrathecal morphine
@nl
type
label
A role for proinflammatory cyt ...... y chronic intrathecal morphine
@ast
A role for proinflammatory cyt ...... y chronic intrathecal morphine
@en
A role for proinflammatory cyt ...... y chronic intrathecal morphine
@nl
prefLabel
A role for proinflammatory cyt ...... y chronic intrathecal morphine
@ast
A role for proinflammatory cyt ...... y chronic intrathecal morphine
@en
A role for proinflammatory cyt ...... y chronic intrathecal morphine
@nl
P2093
P3181
P1476
A role for proinflammatory cyt ...... y chronic intrathecal morphine
@en
P2093
David Martin
Erin D Milligan
Ian N Johnston
Jay Campisi
Julie Wieseler-Frank
Linda R Watkins
Matthew G Frank
Paula Green
Stephen Langer
Steven F Maier
P304
P3181
P356
10.1523/JNEUROSCI.1850-04.2004
P407
P577
2004-08-18T00:00:00Z